Agenus Company
Agenus develops and commercializes immunotherapies and vaccines for cancer and infectious diseases.
(Reupload).png)
Technology:
Peptides and Proteins
Industry:
Peptides and Proteins
Headquarters:
Lexington, Massachusetts, United States
Founded Date:
1994-01-01
Employees Number:
251-500
Funding Status:
IPO
Investors Number:
4
Total Funding:
271140653
Estimated Revenue:
$10M to $50M
Last Funding Date:
2018-10-11
Last Funding Type:
Post-IPO Equity
Register and Claim Ownership